CPChristina Payne

Christina Payne

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christina Payne has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluation of the Immunomodulatory Effects of All-Trans Retinoic Acid Solid Lipid Nanoparticles and Human Mesenchymal Stem Cells in an A549 Epithelial Cell Line Model

    by Christina M. Payne, Liam P. Burke, Brenton Cavanagh, Daniel O’toole, Sally-Ann Cryan, Helena M. Kelly

    Purpose To investigate two potential strategies aimed at targeting the inflammatory pathogenesis of COPD: a small molecule, all trans retinoic acid (atRA) and human mesenchymal stem cells (hMSCs). Methods atRA was formulated into solid lipid nanoparticles (SLNs) via the emulsification-ultrasonication method, and these SLNs were characterised physicochemically. Assessment of the immunomodulatory effects of atRA-SLNs on A549 cells in vitro was determined using ELISA. hMSCs were suspended in a previously developed methylcellulose, collagen and beta-glycerophosphate hydrogel prior to investigating their immunomodulatory effects in vitro. Results SLNs provided significant encapsulation of atRA and also sustained its release over 72 h. A549 cells were viable following the addition of atRA SLNs and showed a reduction in IL-6 and IL-8 levels. A549 cells also remained viable following addition of the hMSC/hydrogel formulation – however, this formulation resulted in increased levels of IL-6 and IL-8, indicating a potentially pro-inflammatory effect. Conclusion Both atRA SLNs and hMSCs show potential for modulating the environment in inflammatory disease, though through different mechanisms and leading to different outcomes – despite both being explored as strategies for use in inflammatory disease. atRA shows promise by acting in a directly anti-inflammatory manner, whereas further research into the exact mechanisms and behaviours of hMSCs in inflammatory diseases is required.


  • A methylcellulose and collagen based temperature responsive hydrogel promotes encapsulated stem cell viability and proliferation in vitro

    by Christina Payne, Eimear B. Dolan, Janice O’sullivan, Sally-Ann Cryan, Helena M. Kelly

    With the number of stem cell-based therapies emerging on the increase, the need for novel and efficient delivery technologies to enable therapies to remain in damaged tissue and exert their therapeutic benefit for extended periods, has become a key requirement for their translation. Hydrogels, and in particular, thermoresponsive hydrogels, have the potential to act as such delivery systems. Thermoresponsive hydrogels, which are polymer solutions that transform into a gel upon a temperature increase, have a number of applications in the biomedical field due to their tendency to maintain a liquid state at room temperature, thereby enabling minimally invasive administration and a subsequent ability to form a robust gel upon heating to physiological temperature. However, various hurdles must be overcome to increase the clinical translation of hydrogels as a stem cell delivery system, with barriers including their low tensile strength and their inadequate support of cell viability and attachment. In order to address these issues, a methylcellulose based hydrogel was formulated in combination with collagen and beta glycerophosphate, and key development issues such as injectability and sterilisation processes were examined. The polymer solution underwent thermogelation at ~36 °C as determined by rheological analysis, and when gelled, was sufficiently robust to resist significant disintegration in the presence of phosphate buffered saline (PBS) while concomitantly allowing for diffusion of methylene blue dye solution into the gel. We demonstrate that human mesenchymal stem cells (hMSCs) encapsulated within the gel remained viable and showed raised levels of dsDNA at increasing time points, an indication of cell proliferation. Mechanical testing showed the “injectability”, i.e. force required for delivery of the polymer solution through devices such as a syringe, needle or catheter. Sterilisation of the freeze-dried polymer wafer via gamma irradiation showed no adverse effects on the formed hydrogel characteristics. Taken together, these results indicate the potential of this gel as a clinically translatable delivery system for stem cells and therapeutic molecules in vivo.


  • Hydrogels from amphiphilic star block copolypeptides

    by R. Murphy, T. Borase, C. Payne, J. O'DWyer, S.-A. Cryan, A. Heise

    A range of 8-arm star-shaped diblock copolypeptides were developed to investigate their potential as self-assembling amphiphiles in aqueous media. These star-shaped block copolypeptides were sythesised by sequential N-carboxyanhydride (NCA) polymerisation from a polypropylene imine (PPI) dendrimer core to comprise a poly(L-lysine) core and poly(L-tyrosine), poly(L-phenylalanine), poly(L-valine) and poly(L-alanine) outer blocks. All star block copolypeptides except the poly(alanine) copolymer spontaneously self-assemble into hydrogels at a low polymer concentration of ≤2 wt%. Investigation of the secondary structure by FTIR and Circular Dichroism (CD) spectroscopy confirm a largely random coil conformation. The hydrogels were further investigated for their viscoelastic properties revealing a strong structure dependence of the hydrogel strength. The highest gel strength was achieved with the star block copolypeptide containing the poly(L-phenylalanine) outer blocks. The versatility of the hydrophilic/hydrophobic system allows for straightforward modification of the hydrophobic sequence, which can be utilised to modulate the mechanical strength for various applications.


  • Biomaterial‐Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives

    by Hugh S. O'NEill, Laura B. Gallagher, Janice O'SUllivan, William Whyte, Clive Curley, Eimear Dolan, Aamir Hameed, Joanne O'DWyer, Christina Payne, Daniel O'REilly, et al.

    Heart failure is a significant clinical issue. It is the cause of enormous healthcare costs worldwide and results in significant morbidity and mortality. Cardiac regenerative therapy has progressed considerably from clinical and preclinical studies delivering simple suspensions of cells, macromolecule, and small molecules to more advanced delivery methods utilizing biomaterial scaffolds as depots for localized targeted delivery to the damaged and ischemic myocardium. Here, regenerative strategies for cardiac tissue engineering with a focus on advanced delivery strategies and the use of multimodal therapeutic strategies are reviewed.